IMAX Maintains Buy Rating by Rosenblatt -- Price Target Steady at $47

Rosenblatt analyst Steve Frankel maintained a Buy rating for IMAX with an adjusted price target set at $47.00. This represents a steady stance from the firm's previous rating, which also had a price target of $47.00.

Rosenblatt signifies confidence in IMAX's future performance despite the stock's current valuation. The unchanged price target of $47.00 suggests that analysts believe the company has solid growth prospects, which may be driven by its innovative technology and strong brand recognition in the entertainment industry.

‍

Link to full article